Cardiolipin biosynthesis in the isolated heart

Little is known about how cardiolipin is synthesized in the heart under normal conditions. Prior research has shown that phosphatidic acid is a precursor in phospholipid synthesis. However, the specific pathway for cardiolipin biosynthesis in the intact heart remains unclear. Existing studies focus on isolated cell types or in vitro models. This gap motivated researchers to investigate cardiolipin biosynthesis in the whole, perfused rat heart. No prior work had resolved the role of phosphatidic acid in this process. The study aimed to clarify the sequence of enzymatic steps involved. Understanding this pathway could provide insights into heart lipid homeostasis. This paper contributes by directly measuring phospholipid labeling in a whole-organ model.

The goal was to determine the biosynthetic pathway of cardiolipin in the intact rat heart. The researchers wanted to identify the rate-limiting step in cardiolipin synthesis. They used radiolabeled glycerol and phosphate to track lipid synthesis in real time. The Langendorff perfusion system allowed them to study the heart in a controlled environment. By measuring radioactivity in phospholipids, they aimed to map the pathway from glycerol to cardiolipin. The study also tested whether phosphatidic acid serves as a precursor. Researchers hypothesized that the Kennedy pathway is involved in this process. Their findings may clarify how the heart regulates lipid synthesis.

Hearts were isolated and perfused in the Langendorff mode for up to 60 minutes. The perfusion buffer contained radiolabeled glycerol or phosphate to trace lipid synthesis. Radioactivity in phospholipids was measured using organic phase analysis. Hearts were also pulsed with [1,(3)-3H]glycerol and chased with unlabeled glycerol. This allowed tracking of radioactivity movement between phospholipid classes. The researchers measured changes in phosphatidic acid, phosphatidylglycerol, and cardiolipin. They also assessed the role of CDP-sn-1,2-diacylglycerol in the process. Enzyme activities were inferred from labeling patterns over time.

Radioactivity from [U-14C]glycerol increased in phosphatidylglycerol and cardiolipin over time. Phosphatidic acid showed a corresponding loss of radioactivity. Hearts perfused with [1,(3)-3H]glycerol showed increased radioactivity in phosphatidic acid and other phospholipids. [32P]Pi perfusion revealed a time-dependent increase in all phospholipids. Glycerol concentrations did not affect phospholipid levels. Pulse-chase experiments showed radioactivity moving from phosphatidic acid to phosphatidylglycerol and cardiolipin. Radioactivity in CDP-sn-1,2-diacylglycerol remained constant. The data suggest phosphatidic acid is a key precursor in cardiolipin synthesis.

The findings suggest that cardiolipin is synthesized from phosphatidic acid via the Kennedy pathway in the heart. The rate-limiting step appears to be the conversion of phosphatidic acid to CDP-sn-1,2-diacylglycerol. The study supports the idea that phosphatidylglycerol is an intermediate in this process. Radioactivity patterns indicate active synthesis of polyglycerophospholipids. The researchers postulate that the heart uses newly synthesized phosphatidic acid for this pathway. No significant radioactivity was detected in phosphatidylglycerol phosphate. The results do not confirm the role of phosphatidylglycerol phosphate in the pathway. These conclusions are based on the observed labeling patterns and enzyme activities.